High prevalence of non-virus/non-alcohol-related alanine-aminotransferase increase in blood donors
Morisco, F.; Di Lonardo, A.; Stroffolini, T.; Leone, D.; Caporaso, N.
Haematologica 86(10): 1116
2001
ISSN/ISBN: 0390-6078 PMID: 11602426 Document Number: 531628
Document emailed within 1 workday
Related Documents
Tseng, G-Chin.; Peng, Y-Chun.; Wang, H-Hui.; Lee, F-Hui.; Huang, L-Ru. 2008: Matrix metalloproteinases 2 and 9 correlate with alanine aminotransferase and hepatitis C virus in blood donors Hepato-Gastroenterology 55(82-83): 535-538Kusendová, K.ín.; Gavorník, P.; Sabaka, P.; Sviteková, K.ár. 2016: Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy Vnitrni Lekarstvi 62(1): 9-16
Bergmeyer, H.U.; Hørder, M.; Rej, R. 1986: International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2) Journal of Clinical Chemistry and Clinical Biochemistry 24(7): 481-495
Nissen, C.B.; Falkenberg, T.E.; Primdahl, J.; Hørslev-Petersen, K. 2013: The effect of alcohol and fatty foods on the P-alanine aminotransferase level in rheumatoid- and psoriatic arthritis patients Ugeskrift for Laeger 175(49): 3013-3017
Wang, C-Shan.; Wang, S-Tair.; Chang, T-Tsung.; Yao, W-Jen.; Chou, P. 2002: Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression Archives of Internal Medicine 162(7): 811-815
Shoaf, E.H. 1990: Hemochromatosis discovered through blood donor screening for alanine aminotransferase North Carolina Medical Journal 51(9): 443-445
Bavazzano, P.; Benassi, S.; Forzieri, R.; Petrioli, G. 1981: Levels of aspartate aminotransferase and alanine aminotransferase in two factories with various hepato-toxic risks Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 17(4): 407-420
Bange, C.; Bange-Barnoud, R.; Nghia, L.T. 1972: Modifications of alanine aminotransferase, aspartate aminotransferase and certain plasma and tissue substrates of the rat during hypercapnia Journal de Physiologie 65(Suppl 3): 342a
Howie, A.F.; Spencer, E.; Beckett, G.J. 1992: Aspartate aminotransferase, alanine aminotransferase, and glutathione transferase in plasma during and after sedation by low-dose isoflurane or midazolam Clinical Chemistry 38(4): 476-479
Orzechowski, S.; Socha-Hanc, J.; Paszkowski, A. 1999: Alanine aminotransferase and glycine aminotransferase from maize (Zea mays L.) leaves Acta Biochimica Polonica 46(2): 447-457
Zhiburt, E.B.; Kodenev, A.T. 2009: Prescreening of the activity of alanine aminotransferase enhances the cost-effectiveness of blood storage Klinicheskaia Laboratornaia Diagnostika 11: 14-16
Hewitt, J.; Harte, D.; Sutherland, M.; Croucher, D.; Fouche, L.; Flanagan, P.; Williamson, D. 2018: Prevalence of hepatitis e virus antibodies and infection in New Zealand blood donors New Zealand Medical Journal 131(1469): 38-43
Tseng, T-Chung.; Liu, C-Jen.; Wang, C-Chi.; Chen, P-Jer.; Lai, M-Yang.; Chen, D-Shinn.; Kao, J-Horng. 2009: Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels Antiviral Therapy 14(2): 203-210
Khouri, S.T.; Edmundo Lopes, P.A.; Perez, R.M.; Figueiredo, V.M.; Lanzoni, V.P.; Silva, A., E.B.; Lucia, M. G. Ferraz 2004: Determination of Alanine Aminotransferase in Blood Donor Screening - Evidence of its Usefulness in the Prevention of Post-Transfusion Hepatitis Clinical Laboratory 50(5-6): 291-294
Gwanzura, L.; Chigonda, T.G.; Mvere, D.; De Villiers, D.M.; Siziya, S.; Mason, P.R. 2002: The prevalence of Herpes simplex virus type-2 infection in blood donors in Harare, Zimbabwe Central African Journal of Medicine 48(3-4): 38-42
Namululi, B.A.; Guerrieri, C.; Dramaix, M.W. 2013: Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion. A study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo Revue d'Epidemiologie et de Sante Publique 61(2): 139-144
Silverman, A.L.; Piquette, D.L.; Filipiak, C.L.; Neill, J.S.; Bayati, N.; Gordon, S.C. 1997: Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels American Journal of Gastroenterology 92(10): 1793-1795
Elavia, A.J.; Banker, D.D. 1991: Prevalence of hepatitis B surface antigen and its subtypes in high risk group subjects and voluntary blood donors in Bombay Indian Journal of Medical Research 93: 280-285
Tønnesen, E.; Sørensen, P.G.; Diederichsen, H.; Martinussen, K. 1981: Antibodies to hepatitis a virus in blood donors. Relationship to age distribution of blood donors Ugeskrift for Laeger 143(49): 3301-3303
Morisco, F.; Rosmini, F. 2002: Reliability of measurements of serum alanine transaminase activity and the impact on the cut-off value for the selection of blood donors Haematologica 87(5): 559-560